Paper29367243
Immunogenicity in Rabbits of HIV-1 SOSIP Trimers from Clades A, B, and C, Given Individually, Sequentially, or in Combination.
Torrents de la Peña A and 9 others. J Virol, 2018. Cited by 76 papers, by iCite.
Cite this record
ConductScience Library. Immunogenicity in Rabbits of HIV-1 SOSIP Trimers from Clades A, B, and C, Given Individually, Sequentially, or in Combination. Papers, record 29367243. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/29367243
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| AIDS Vaccines | Major topic |
| HIV-1 | Major topic |
| Immunogenicity, Vaccine | Major topic |
| Protein Multimerization | Major topic |
| env Gene Products, Human Immunodeficiency Virus | Major topic |
| Animals | |
| Humans | |
| Rabbits |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| 280829 | European Research Council | International | PubMed | PubMed | |
| P01 AI110657 | NIAID NIH HHS | United States | P01AI110657 | PubMed and NIH | NIH RePORTER |
References26
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 24068931 | A next-generation cleaved, soluble HIV-1 Env trimer, BG505 SOSIP.664 gp140, expresses multiple epitopes for broadly neutralizing but not non-neutralizing antibodies. | PLoS Pathog | 2013 | https://conductscience.org/library/papers/24068931 | PubMed |
| 2 | 26457756 | Viral variants that initiate and drive maturation of V1V2-directed HIV-1 broadly neutralizing antibodies. | Nat Med | 2015 | https://conductscience.org/library/papers/26457756 | PubMed |
| 3 | 25540368 | A multivalent clade C HIV-1 Env trimer cocktail elicits a higher magnitude of neutralizing antibodies than any individual component. | J Virol | 2015 | https://conductscience.org/library/papers/25540368 | PubMed |
| 4 | 28834745 | Improving the Immunogenicity of Native-like HIV-1 Envelope Trimers by Hyperstabilization. | Cell Rep | 2017 | https://conductscience.org/library/papers/28834745 | PubMed |
| 5 | 23086475 | Evolution of an HIV glycan-dependent broadly neutralizing antibody epitope through immune escape. | Nat Med | 2012 | https://conductscience.org/library/papers/23086475 | PubMed |
| 6 | 26372963 | Design and structure of two HIV-1 clade C SOSIP.664 trimers that increase the arsenal of native-like Env immunogens. | Proc Natl Acad Sci U S A | 2015 | https://conductscience.org/library/papers/26372963 | PubMed |
| 7 | 28133806 | Native-like Env trimers as a platform for HIV-1 vaccine design. | Immunol Rev | 2017 | https://conductscience.org/library/papers/28133806 | PubMed |
| 8 | 26687358 | Immunogenicity of Stabilized HIV-1 Envelope Trimers with Reduced Exposure of Non-neutralizing Epitopes. | Cell | 2015 | https://conductscience.org/library/papers/26687358 | PubMed |
| 9 | 25662010 | Manipulating the selection forces during affinity maturation to generate cross-reactive HIV antibodies. | Cell | 2015 | https://conductscience.org/library/papers/25662010 | PubMed |
| 10 | 15709015 | Multiclade human immunodeficiency virus type 1 envelope immunogens elicit broad cellular and humoral immunity in rhesus monkeys. | J Virol | 2005 | https://conductscience.org/library/papers/15709015 | PubMed |
| 11 | 27627672 | Sequential and Simultaneous Immunization of Rabbits with HIV-1 Envelope Glycoprotein SOSIP.664 Trimers from Clades A, B and C. | PLoS Pathog | 2016 | https://conductscience.org/library/papers/27627672 | PubMed |
| 12 | 27114034 | Trimeric HIV-1-Env Structures Define Glycan Shields from Clades A, B, and G. | Cell | 2016 | https://conductscience.org/library/papers/27114034 | PubMed |
| 13 | 26506369 | Longitudinal Antigenic Sequences and Sites from Intra-Host Evolution (LASSIE) Identifies Immune-Selected HIV Variants. | Viruses | 2015 | https://conductscience.org/library/papers/26506369 | PubMed |
| 14 | 20170767 | Antibody responses elicited through homologous or heterologous prime-boost DNA and protein vaccinations differ in functional activity and avidity. | Vaccine | 2010 | https://conductscience.org/library/papers/20170767 | PubMed |
| 15 | 26766578 | Broadly Neutralizing Antibody Responses in a Large Longitudinal Sub-Saharan HIV Primary Infection Cohort. | PLoS Pathog | 2016 | https://conductscience.org/library/papers/26766578 | PubMed |
| 16 | 29166592 | HIV Envelope Glycoform Heterogeneity and Localized Diversity Govern the Initiation and Maturation of a V2 Apex Broadly Neutralizing Antibody Lineage. | Immunity | 2017 | https://conductscience.org/library/papers/29166592 | PubMed |
| 17 | 27545891 | Holes in the Glycan Shield of the Native HIV Envelope Are a Target of Trimer-Elicited Neutralizing Antibodies. | Cell Rep | 2016 | https://conductscience.org/library/papers/27545891 | PubMed |
| 18 | 25589637 | A native-like SOSIP.664 trimer based on an HIV-1 subtype B env gene. | J Virol | 2015 | https://conductscience.org/library/papers/25589637 | PubMed |
| 19 | 16616287 | Polyvalent HIV-1 Env vaccine formulations delivered by the DNA priming plus protein boosting approach are effective in generating neutralizing antibodies against primary human immunodeficiency virus type 1 isolates from subtypes A, B, C, D and E. | Virology | 2006 | https://conductscience.org/library/papers/16616287 | PubMed |
| 20 | 26089353 | HIV-1 VACCINES. HIV-1 neutralizing antibodies induced by native-like envelope trimers. | Science | 2015 | https://conductscience.org/library/papers/26089353 | PubMed |
Cited by71
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 76 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42984752 | Immunogenicity and structure of a stabilized HIV-1 clade C Env from a pediatric elite neutralizer in complex with an autologous bnAb. | Front Immunol | 2026 | https://conductscience.org/library/papers/42984752 | PubMed |
| 42012184 | Recent advances in HIV-1 envelope-based vaccine designs for guiding broadly neutralizing antibody response. | J Virol | 2026 | https://conductscience.org/library/papers/42012184 | PubMed |
| 41959402 | Decoding epitope immunodominance in HIV Env using cryoEM and machine learning. | bioRxiv | 2026 | https://conductscience.org/library/papers/41959402 | PubMed |
| 41884456 | Human immunodeficiency virus vaccines: Advances, challenges and future perspectives. | World J Virol | 2026 | https://conductscience.org/library/papers/41884456 | PubMed |
| 41238582 | Novel HIV-1 fusion peptide immunogens using glycan-engineered alphavirus-like particles. | NPJ Vaccines | 2025 | https://conductscience.org/library/papers/41238582 | PubMed |
| 40835839 | Immunofocusing on the conserved fusion peptide of HIV envelope glycoprotein in rhesus macaques. | NPJ Vaccines | 2025 | https://conductscience.org/library/papers/40835839 | PubMed |
| 40511646 | Germline-Targeting Strategies to Induce bNAbs against HIV-1. | Curr HIV Res | 2026 | https://conductscience.org/library/papers/40511646 | PubMed |
| 40006695 | Progress and Challenges in HIV-1 Vaccine Research: A Comprehensive Overview. | Vaccines (Basel) | 2025 | https://conductscience.org/library/papers/40006695 | PubMed |
| 40006657 | The Design and Immunogenicity of an HIV-1 Clade C Pediatric Envelope Glycoprotein Stabilized by Multiple Platforms. | Vaccines (Basel) | 2025 | https://conductscience.org/library/papers/40006657 | PubMed |
| 39823319 | Anti-immune complex antibodies are elicited during repeated immunization with HIV Env immunogens. | Sci Immunol | 2025 | https://conductscience.org/library/papers/39823319 | PubMed |
| 39651156 | Immunofocusing on the conserved fusion peptide of HIV envelope glycoprotein in rhesus macaques. | bioRxiv | 2025 | https://conductscience.org/library/papers/39651156 | PubMed |
| 39508605 | Inducible cell lines producing replication-defective human immunodeficiency virus particles containing envelope glycoproteins stabilized in a pretriggered conformation. | J Virol | 2024 | https://conductscience.org/library/papers/39508605 | PubMed |
| 39361585 | Mosaic and mixed HIV-1 glycoprotein nanoparticles elicit antibody responses to broadly neutralizing epitopes. | PLoS Pathog | 2024 | https://conductscience.org/library/papers/39361585 | PubMed |
| 39248459 | Conformations of membrane human immunodeficiency virus (HIV-1) envelope glycoproteins solubilized in Amphipol A18 lipid-nanodiscs. | J Virol | 2024 | https://conductscience.org/library/papers/39248459 | PubMed |
| 38979012 | Membrane HIV-1 envelope glycoproteins stabilized more strongly in a pretriggered conformation than natural virus Envs. | iScience | 2024 | https://conductscience.org/library/papers/38979012 | PubMed |
| 38605096 | CoPoP liposomes displaying stabilized clade C HIV-1 Env elicit tier 2 multiclade neutralization in rabbits. | Nat Commun | 2024 | https://conductscience.org/library/papers/38605096 | PubMed |
| 38582771 | Triple tandem trimer immunogens for HIV-1 and influenza nucleic acid-based vaccines. | NPJ Vaccines | 2024 | https://conductscience.org/library/papers/38582771 | PubMed |
| 38085509 | Development of LIBRA-seq for the guinea pig model system as a tool for the evaluation of antibody responses to multivalent HIV-1 vaccines. | J Virol | 2024 | https://conductscience.org/library/papers/38085509 | PubMed |
| 37696048 | Alterations in gp120 glycans or the gp41 fusion peptide-proximal region modulate the stability of the human immunodeficiency virus (HIV-1) envelope glycoprotein pretriggered conformation. | J Virol | 2023 | https://conductscience.org/library/papers/37696048 | PubMed |
| 37640732 | Engaging an HIV vaccine target through the acquisition of low B cell affinity. | Nat Commun | 2023 | https://conductscience.org/library/papers/37640732 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ERVK-20 | 100616444 | PubTator's text mining | https://conductscience.org/library/genes/100616444 | NCBI Gene |
| ITIH4 | 3700 | PubTator's text mining | https://conductscience.org/library/genes/3700 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/29367243
GET https://conductscience.org/api/papers/v1/29367243/references?page=2